4.8 Article

T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1

Journal

EMBO JOURNAL
Volume 30, Issue 9, Pages 1742-1752

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/emboj.2011.85

Keywords

AP-1; cytokine; MAP kinase; signal transduction; ubiquitination

Funding

  1. Interuniversity Attraction Poles program [IAP6/18)]
  2. FWO [G.0089.10]
  3. Belgian Foundation against Cancer
  4. 'Strategic Basis Research program' of the IWT
  5. Centrum voor Gezwelziekten
  6. Concerted Research Actions (GOA) [01G06B6]
  7. 'Group-ID MRP' initiative of the Ghent University

Ask authors/readers for more resources

The paracaspase mucosa-associated lymphoid tissue 1 (MALT1) is central to lymphocyte activation and lymphomagenesis. MALT1 mediates antigen receptor signalling to NF-kappa B by acting as a scaffold protein. Furthermore, MALT1 has proteolytic activity that contributes to optimal NF-kappa B activation by cleaving the NF-kappa B inhibitor A20. Whether MALT1 protease activity is involved in other signalling pathways, and the identity of the relevant substrates, is unknown. Here, we show that T-cell receptors (TCR) activation, as well as overexpression of the oncogenic API2-MALT1 fusion protein, results in proteolytic inactivation of CYLD by MALT1, which is specifically required for c-jun N-terminal kinase (JNK) activation and the inducible expression of a subset of genes. These results indicate a novel role for MALT1 proteolytic activity in TCR-induced JNK activation and reveal CYLD cleavage as the underlying mechanism. The EMBO Journal (2011) 30, 1742-1752. doi:10.1038/emboj.2011.85; Published online 29 March 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available